Jesse M. Tettero

Amsterdam Neuroscience — Netherlands

Medicine · Health Sciences

11h-index1.0kcitations50works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(37), Hematopoietic Stem Cell Transplantation(11), Cancer Genomics and Diagnostics(8), Myeloproliferative Neoplasms: Diagnosis and Treatment(8), Acute Lymphoblastic Leukemia research(7)

Publications50 total

Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia
Leukemia·2026Open Access
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia – a HARMONY study
Leukemia·2026Open Access
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
Leukemia·2025Open Access
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission
2025Open Access
Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials
Blood·2025· 1 citedOpen Access
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Blood·2025Open Access
Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia
Blood·2025
Measurable residual disease monitoring in acute myeloid leukaemia: Techniques, timing and therapeutic implications
Seminars in Hematology·2025· 2 citedOpen Access
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.
Apollo (University of Cambridge)·2025Open Access
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients
Haematologica·2025· 1 citedOpen Access
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Blood Advances·2025· 17 citedOpen Access
Significant Inter-Laboratory Variability in Measurable Residual Disease Multiparameter Flow Cytometry Testing Prior to Allogeneic Transplantation Impedes Outcome Prediction: A CIBMTR Analysis
Transplantation and Cellular Therapy·2025· 1 cited
A data management system for precision medicine
PLOS Digital Health·2025· 4 citedOpen Access
Acute Myeloid Leukemia-Use of Measurable Residual Disease to Improve Outcomes
Advances in experimental medicine and biology·2025· 1 citedOpen Access
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
Haematologica·2024· 3 citedOpen Access
Leukemic Phenotype Determines Prognostic Relevance of Limit of Quantification for Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia
Blood·2024
The Prognostic Impact of Myelodysplasia-Related Gene Mutations in Acute Myeloid Leukemia with <i>FLT3</i>-ITD Mutations
Blood·2024
Acute myeloid leukemia: does sex matter?
Leukemia·2024· 13 citedOpen Access
AML-348 Impact of Hemodilution on Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2024
Impact of Hemodilution on Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2024
page 1 of 3Next →

Frequent Co-authors

Gert J. Ossenkoppele(29), Jacqueline Cloos(28), Lok Lam Ngai(23), Costa Bachas(22), Peter J.M. Valk(17), Angèle Kelder(15), Lars Bullinger(14), Willemijn J. Scholten(14), Patrycja Gradowska(13), Marta Sobas(13), Bjørn Tore Gjertsen(12), Markus G. Manz(12), Bob Löwenberg(12), Eric Sträng(12), Klaus H. Metzeler(12), Javier Martínez Elicegui(12), Jesús María Hernández‐Rivas(12), Konstanze Döhner(11), Ángela Villaverde Ramiro(11), David C. de Leeuw(11)